GTCR and Carlyle-backed Resonetics completed the acquisition of Agile MV.

GTCR and Carlyle-backed Resonetics, a company that specialises in micro manufacturing for life sciences, completed the acquisition of Agile MV, a biotechnology company. Financial terms were not disclosed. "Consistent with our initial investment thesis for Resonetics, the acquisition of Agile strategically enhances our capabilities, and further establishes the company's position as a leading service provider to interventional medical device companies," Tom Burns, Resonetics CEO.